Platform Archives | Page 2 of 3

ISMB – 2022 – Poster Presentation 859

TransACT enhances detection and characterization of translocation events from high-throughput sequencing data at base-pair resolution for gene editing products […]

EHA – 2022 – Poster Presentation 1429

Multiplex Deletion of Myeloid Antigens CD33 and CLL-1 by CRISPR/Cas9 in Human Hematopoietic Stem Cells Highlights the Potential of Next-Generation Transplantation for AML Treatment […]

ASGCT – 2022 – Poster Presentation Tu-117

A Novel Scalable Electroporation Platform for the Manufacturing of Gene Modified Hematopoietic Stem and Progenitor Cell Therapies […]

ISGCT – 2022 – Poster Presentation 933

Novel Automated, Functionally Closed System for Rapid Immunomagnetic Negative Selection of T Cells […]

Keystone Symposia – 2022 – Poster Presentation 3002

Multiplex Editing of Hematopoietic Stem and Progenitor Cells (HSPCs) with CRISPR Cas Nucleases Achieves High On Target Editing with Undetectable Translocations […]

Keystone Symposia – 2022 – Poster Presentation 3001

Multiplex Base Editing in Human Hematopoietic Stem and Progenitor Cells (HSPCs) Enables Efficient Removal of Multiple Surface Antigens in Acute Myeloid Leukemia (AML) Immunotherapy […]

ASH Annual Meeting 2021 – Poster Presentation 1716

G-CSF/Plerixafor Dual-Mobilized Donor Derived CD33CAR T-Cells as Potent and Effective AML Therapy in Pre-Clinical Models […]

ASH Annual Meeting 2021 – Poster Presentation 2939

Multiplex Engineering of Human CD34+ HSPCs Enables Dual Gene Knockout While Maintaining High Engraftment Potential and Safety […]

ASH Annual Meeting 2021 – Poster Presentation 3818

Knock Out of CD123 or CLL-1 by CRISPR-Cas9 Editing From Human Hematopoietic Stem Cell Transplantations Provide New Possibilities for Increasing Therapeutic Index and Safety for AML Treatment […]